TY - JOUR
T1 - Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1
T2 - A second type of “autoimmune” hepatitis
AU - Homberg, Jean‐Claude ‐C
AU - Abuaf, Nisen
AU - Bernard, Olivier
AU - Islam, Shamsul
AU - Alvarez, Fernando
AU - Khalil, Samir H.
AU - Poupon, Raoul
AU - Darnis, François
AU - Lévy, Victor‐Georges ‐G
AU - Grippon, Patrick
AU - Opolon, Pierre
AU - Bernuau, Jacques
AU - Benhamou, Jean‐Pierre ‐P
AU - Alagille, Daniel
PY - 1987/1/1
Y1 - 1987/1/1
N2 - Sixty‐five patients with histologically proven chronic active hepatitis of unknown cause but associated with the antiliver/kidney microsome antibody type 1, confirmed by immunofluorescence and immunoprecipitation, were selected as forming a special entity. This disease was found to be rare with a prevalence of 5/1,000,000. The female to male ratio was 8:1. The condition occurred at all ages but was most common between the ages of 2 and 14 years. In 22 of the 65 cases, the hepatitis was associated with an autoimmune disease, most commonly insulin‐dependent diabetes, autoimmune thyroid disease and vitiligo. The same autoimmune diseases were present in first‐degree relatives from seven families. In 36 cases, the onset of disease resembled acute viral hepatitis. Serum biochemical tests showed marked elevation in aminotransaminases and hypergammaglobulinemia. Paradoxically, serum and salivary IgA levels were often normal or low. Histologic findings were multifocal hepatic necrosis with bridging in the acute stage, and aggressive hepatitis with mono‐nuclear cell infiltration or macronodular cirrhosis in the late stages. Serologically, apart from the presence of antiliver/kidney microsome antibody type 1, the disease was characterized by the absence of antiactin, antimitochondria and antinucleus antibodies; however, organ‐specific autoantibodies were often present. The clinical course was usually severe: six patients in the acute stage presented with fulminant hepatitis, and all, except two, other patients progressed to cirrhosis, Prolonged treatment with corticosteroids and immunosuppressants was usually effective in rendering the cirrhosis inactive. The cumulative survival rate was 51% at 14 years.
AB - Sixty‐five patients with histologically proven chronic active hepatitis of unknown cause but associated with the antiliver/kidney microsome antibody type 1, confirmed by immunofluorescence and immunoprecipitation, were selected as forming a special entity. This disease was found to be rare with a prevalence of 5/1,000,000. The female to male ratio was 8:1. The condition occurred at all ages but was most common between the ages of 2 and 14 years. In 22 of the 65 cases, the hepatitis was associated with an autoimmune disease, most commonly insulin‐dependent diabetes, autoimmune thyroid disease and vitiligo. The same autoimmune diseases were present in first‐degree relatives from seven families. In 36 cases, the onset of disease resembled acute viral hepatitis. Serum biochemical tests showed marked elevation in aminotransaminases and hypergammaglobulinemia. Paradoxically, serum and salivary IgA levels were often normal or low. Histologic findings were multifocal hepatic necrosis with bridging in the acute stage, and aggressive hepatitis with mono‐nuclear cell infiltration or macronodular cirrhosis in the late stages. Serologically, apart from the presence of antiliver/kidney microsome antibody type 1, the disease was characterized by the absence of antiactin, antimitochondria and antinucleus antibodies; however, organ‐specific autoantibodies were often present. The clinical course was usually severe: six patients in the acute stage presented with fulminant hepatitis, and all, except two, other patients progressed to cirrhosis, Prolonged treatment with corticosteroids and immunosuppressants was usually effective in rendering the cirrhosis inactive. The cumulative survival rate was 51% at 14 years.
UR - http://www.scopus.com/inward/record.url?scp=0023555290&partnerID=8YFLogxK
U2 - 10.1002/hep.1840070626
DO - 10.1002/hep.1840070626
M3 - Article
C2 - 3679093
AN - SCOPUS:0023555290
SN - 0270-9139
VL - 7
SP - 1333
EP - 1339
JO - Hepatology
JF - Hepatology
IS - 6
ER -